This study employs a comprehensive bioinformatics approach to investigate the role of CPLX1 as a novel prognostic biomarker in colorectal cancer (CRC), particularly in relation to immunotherapy resistance and ferroptosis. This evidence concerns the gene CPLX1 and colorectal carcinoma.